课题基金 / 基金详情

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
单相重度抑郁症药物的优化预测治疗 (OPTIMUM-D)
批准号：
469292
负责人：
Uher Rudolf
金额：
$108.95万
依托单位：
Nova Scotia Health Authority (Halifax)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-09-01 至 2027-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=469292&lang=en
关键词：
Antidepressants Clinical Trial Combined Treatment Major Depressive Disorder Personalized Treatment Pharmacotherapy

项目摘要

项目成果

Uher Rudolf的其他基金

相似基金

相关文献

中文摘要
翻译
一些抑郁症患者对抗抑郁药反应良好，但另一些人需要两种药物的组合才能好转。目前的标准做法是先开一种抗抑郁药，等8周后再开一剂。
英文摘要
Some people with depression respond well to an antidepressant but others require a combination of two medications to get better. The current standard practice is to prescribe an antidepressant first, wait 8 weeks for response and then prescribe an additio
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of the COVID-19 pandemic on mental health of children of parents living with mental illness
Brain development and the onset of depression in youth
Brain development and the onset of depression in youth
Impact of the COVID-19 pandemic on Canadians living with mental illness, and their children
海外基金